Join us in Philadelphia this September for the DTRF "Together We Will" Weekend: - Register today!

The Desmoid Tumor Research Foundation

August 2016

Desmoid fibromatosis: MRI features of response to systemic therapy.

Author Information

Andrew E Rosenberg,Breelyn A Wilky,H Thomas Temple,Jonathan C Trent,Jonathan Cohen,Pooja J Sheth,Spencer Del Moral,Ty K Subhawong

Center for Orthopedic Innovations, 3659 S. Miami Avenue, Suite 4008, Miami, FL, 33133, USA.,Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.,Department of Radiology, University of Miami Miller School of Medicine/Jackson Memorial Hospital, 1611 NW 12th Avenue, JMH WW 279, Miami, FL, 33136, USA.,Department of Radiology, University of Miami Miller School of Medicine/Jackson Memorial Hospital, 1611 NW 12th Avenue, JMH WW 279, Miami, FL, 33136, USA. tsubhawong@med.miami.edu.,Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center, Miami, FL, 33136, USA.,Oncology and Radiation Associates, 1321 NW 14th Street, Suite 207, Miami, FL, 33125, USA.

Publication

Summary

Imaging criteria for measuring the response of desmoid fibromatosis to systemic therapy are not well established. We evaluated a series of patients with desmoids who underwent systemic therapy to document magnetic resonance imaging (MRI) features associated with a positive clinical response.

View Abstract